Loading chat...
NY A05285
Bill
Status
Passed
3/20/2025
Primary Sponsor
Karines Reyes
Click for details
AI Summary
- Amends existing law to allow prescription labels for mifepristone or misoprostol to include the name or address of the dispensing health care practice instead of the individual dispenser's name
- Requires that at the prescriber's request, prescription labels for mifepristone or misoprostol shall include the name or address of the prescribing health care practice instead of the prescriber's personal name
- Mandates health care prescribers inform patients when they have included or requested to include the practice name or address instead of their personal name on the prescription label
- Removes references to "generic alternatives" from the prior labeling law provisions
- Takes effect on the same date as the related 2025 law (S. 36-A and A. 2145-A) regarding labeling of mifepristone and misoprostol
Legislative Description
Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.
Last Action
signed chap.108
3/20/2025
Committee Referrals
Rules3/5/2025
Rules2/24/2025
Higher Education2/12/2025
Full Bill Text
No bill text available